Sun Pharmaceutical Industries has acquired the 12 per cent stake of Mark Mobius-headed Templeton Asset Management in its Israeli subsidiary, Taro Pharmaceuticals, for $82 million (Rs364 crore). Sun paid $16 per share, about 14 per cent premium to Taro's current market price of $13.75.

With this, Sun Pharma increased its Taro stake to 65.2 per cent from 53.2 per cent. Taro is a pink sheets-listed company on the New York Stock Exchange. The deal will help the Indian drug maker to get a crucial 77 per cent voting right on management decisions related to Taro. Templeton invested in Taro in 2005, and increased its stake in 2006, when Taro's shares were trading at $12. Templeton bought more shares in 2007 at between $6.50 and $7.20 per share.crackcrack

Sun Pharma Inds. Share Price

1634.40 21.85 (1.35%)
22-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1217.15
Cipla 1371.55
Zydus Lifesciences 884.85
Lupin 2165.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×